Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2006

01-09-2006 | Epidemiology

Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene

Authors: Bartłomiej Masojć, Marek Mierzejewski, Cezary Cybulski, Thierry van de Wetering, Tadeusz Dębniak, Bohdan Górski, Ewa Jaworowska, Czesława Tarnowska, Marcin Lenner, Rodney J Scott, Jan Lubiński

Published in: Breast Cancer Research and Treatment | Issue 1/2006

Login to get access
Metadata
Title
Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene
Authors
Bartłomiej Masojć
Marek Mierzejewski
Cezary Cybulski
Thierry van de Wetering
Tadeusz Dębniak
Bohdan Górski
Ewa Jaworowska
Czesława Tarnowska
Marcin Lenner
Rodney J Scott
Jan Lubiński
Publication date
01-09-2006
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2006
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9180-5

Other articles of this Issue 1/2006

Breast Cancer Research and Treatment 1/2006 Go to the issue

Erratum

Optical coherence tomography in tamoxifen retinopathy

OriginalPaper

Prediction of breast cancer using volatile biomarkers in the breath

Letter to the Editor

Optical coherence tomography in tamoxifen retinopathy

Preclinical study

Telomerase immortalization of human mammary epithelial cells derived from a BRCA2 mutation carrier

OriginalPaper

Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients

Preclinical study

Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits